AgendaSaturday, October 12, 2024

9:00 AM - 9:05 AM

Opening Remarks

9:05 AM - 10:05 AM

Ready, Set, Act: Empowering Patients with Seizure Action Plans

Presented by Danielle Becker, MD

This session is designed for healthcare professionals aiming to improve their expertise in seizure management through the development and implementation of personalized seizure action plans. Participants will learn to justify the need for these plans, identify their critical elements, formulate effective counseling strategies, and identify pharmacologic options for managing breakthrough seizures. By the end of the session, attendees will be proficient in creating comprehensive seizure action plans that enhance patient safety and care.

10:05 AM - 10:10 AM

5-Minute Break

10:10 AM - 11:10 AM

Non-CME Educational Session

MDOutlook / Clinical Care Solutions, a CEA Company

Advancements In Rett Syndrome (RTT) Care

Sponsored by Acadia Pharmaceuticals Inc. Presented by Shannon Standridge, DO and Arthur Beisang, MD

Learn about the latest treatment approaches for managing patients living with RTT from the perspectives of RTT experts and a caregiver. This non-CME educational program is sponsored by Acadia Pharmaceuticals Inc.

11:10 AM - 11:15 AM

5-Minute Break

11:15 AM - 12:15 PM

Gut Microbiome in Neurologic Health

Presented by Christopher Lowry, MD

Emerging research shows that the complex microbiota resident in the human gut can affect our health in numerous ways. This session will focus on neurological impact of the gut microbiome, including evidence for etiologic and symptomatic roles in neurologic disorders and exploring potential for prognostic and therapeutic use.

12:15 PM - 12:20 PM

5-Minute Break

12:20 PM - 1:20 PM

Non-CME Educational Session

MDOutlook / Clinical Care Solutions, a CEA Company

Managing Hyperkinetic Movement Disorders: From Symptoms and Impacts to Approved Treatment

Presented by Sandeep K. Thakkar, DO

This program provides an overview of tardive dyskinesia and Huntington’s disease (HD) chorea, including phenomenology, prevalence, impacts, and risk factors. Faculty will share the clinical data for an FDA-approved treatment option for adults with tardive dyskinesia and HD chorea. In addition, participants will have the opportunity to examine cases of patients with tardive dyskinesia and those with HD chorea by observing videos of the patients before and after treatment. This non-CME educational program is sponsored by Neurocrine Biosciences.

1:20 PM - 1:25 PM

5-Minute Break

1:25 PM - 2:25 PM

Stepping Stones to Stability: A Closer Look at Identifying and Treating Huntington's Disease Chorea

Presented by Adys Mendizabal, MD, MS

This session will cover clinical strategies for identification and management of chorea associated with HD, including patient/caregiver communication, interdisciplinary care coordination, and available pharmacologic treatments.

2:25 PM - 2:30 PM

5-Minute Wellness Break

2:30 PM - 3:30 PM

Early Detection, Better Care: Migraine Diagnosis and Treatment

Presented by Nada Hindiyeh, MD

In this session, participants will learn to apply advanced screening and diagnostic techniques, assess cutting-edge treatments, and evaluate patient-specific needs for preventive care. By the end of the session, attendees will be equipped with the knowledge and skills to improve patient outcomes through personalized and evidence-based approaches to migraine treatment.

3:30 PM - 3:35 PM

5-Minute Wellness Break

3:35 PM - 4:35 PM

Agitation, Psychosis, and other Behavioral Symptoms in Alzheimer’s Disease

Presented by David Sultzer, MD

This presentation will describe the phenomenology, neurobiological mechanisms, and management of neuropsychiatric symptoms in Alzheimer's disease and other dementias, including agitation, psychosis, mood changes, and apathy. Overall management approaches, findings from treatment trials, and novel approaches in development will be discussed.

4:35 PM - 4:45 PM

Closing Remarks